Recently, using an experimental CKD model, Singh et al. reported that activation of FGFR4 and PLCg/calcineurin/NFAT signaling by FGF23 in the liver stimulated an inflammatory response (40). This evidence concerns the gene FGFR4 and chronic kidney disease.